Depressive symptoms during pregnancy: impact on neuroendocrine and neonatal outcomes.
Marcus
Sheila
S
Psychiatry Department, University of Michigan, Ann Arbor, MI, USA. smmarcus@umich.edu
Lopez
Juan F
JF
McDonough
Susan
S
Mackenzie
Michael J
MJ
Flynn
Heather
H
Neal
Charles R
CR
Gahagan
Sheila
S
Volling
Brenda
B
Kaciroti
Niko
N
Vazquez
Delia M
DM
D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D003866:Depressive Disorder / Q000150:complications* / Q000523:psychology*; D004522:Educational Status; D005006:Ethnicity; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005333:Fetus / Q000502:physiology; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D007182:Income; D018730:Infant Behavior / Q000502:physiology; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D008032:Limbic System / Q000503:physiopathology; D008137:Longitudinal Studies; D008297:Male; D017533:Marital Status; D009490:Neurosecretory Systems / Q000503:physiopathology*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000523:psychology*; D011256:Pregnancy Outcome / Q000523:psychology*; D012959:Socioeconomic Factors; D055815:Young Adult
D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone